C
Christopher J. Thompson
Researcher at Beaumont Hospital
Publications - 142
Citations - 4183
Christopher J. Thompson is an academic researcher from Beaumont Hospital. The author has contributed to research in topics: Hyponatremia & Hypopituitarism. The author has an hindex of 31, co-authored 124 publications receiving 3428 citations.
Papers
More filters
Journal ArticleDOI
Neuroendocrine dysfunction in the acute phase of traumatic brain injury
Amar Agha,Bairbre Rogers,Darren Mylotte,Faisal Taleb,William Tormey,Jack Phillips,Christopher J. Thompson +6 more
TL;DR: Pituitary hormone abnormalities have been reported in up to 50% of survivors of traumatic brain injury who were investigated several months or longer following the event, and the frequency of pituitary dysfunction in the early post‐TBI period is unknown.
Journal ArticleDOI
The incidence and pathophysiology of hyponatraemia after subarachnoid haemorrhage
Mark Sherlock,Eoin P. O'Sullivan,Amar Agha,Lucy Ann Behan,D. Rawluk,Paul Brennan,William Tormey,Christopher J. Thompson +7 more
TL;DR: A case-note analysis of all patients with subarachnoid haemorrhage admitted to Beaumont Hospital between January 2002 and September 2003 showed that hyponatraemia is common following SAH and is associated with longer hospital stay as mentioned in this paper.
Journal ArticleDOI
Hypothalamic-pituitary dysfunction after irradiation of nonpituitary brain tumors in adults.
Amar Agha,Mark Sherlock,S. Brennan,Stephen A. O’Connor,Eoin P. O'Sullivan,Bairbre Rogers,C. Faul,Daniel Rawluk,William Tormey,Christopher J. Thompson +9 more
TL;DR: Adult patients treated with cranial irradiation for primary nonpituitary brain tumors are at high risk of hypopituitarism, which is time and dose dependent.
Journal ArticleDOI
The syndrome of inappropriate antidiuretic hormone: prevalence, causes and consequences.
TL;DR: This review will examine the prevalence, pathophysiology, clinical characteristics and clinical consequences of hyponatraemia due to SIADH.
Journal ArticleDOI
Heterogeneous Genetic Background of the Association of Pheochromocytoma/Paraganglioma and Pituitary Adenoma: Results From a Large Patient Cohort
Judit Dénes,Francesca Swords,Eleanor Rattenberry,Karen Stals,Martina Owens,Treena Cranston,Paraskevi Xekouki,Linda B. Moran,Ajith Kumar,Christopher A. Wassif,Naomi Fersht,Stephanie E Baldeweg,Damian G. Morris,Stafford L. Lightman,Amar Agha,Aled Rees,Joan Grieve,Michael Powell,Cesar Luiz Boguszewski,Pinaki Dutta,Rajesh V. Thakker,Umasuthan Srirangalingam,Christopher J. Thompson,Maralyn Druce,Claire E Higham,Julian R. E. Davis,Rosalind A. Eeles,Mark Stevenson,Brendan O'Sullivan,Phillipe Taniere,Kassiani Skordilis,Plamena Gabrovska,Anne Barlier,Susan M. Webb,Anna Aulinas,William Drake,John S. Bevan,Cristina Preda,Nadezhda Dalantaeva,Antônio Ribeiro-Oliveira,Isabel Tena Garcia,Galina Yordanova,Violeta Iotova,Jane Evanson,Ashley B. Grossman,Jacqueline Trouillas,Sian Ellard,Sian Ellard,Constantine A. Stratakis,Eamonn R. Maher,Eamonn R. Maher,Federico Roncaroli,Márta Korbonits +52 more
TL;DR: In this article, the authors investigated the possible coexistence of pituitary adenoma and pheo/PGL and found that mutations in the genes known to cause PPGL can rarely be associated with pituitaries, whereas mutation in a gene predisposing to Pituitary Adenomas (MEN1) can be associated this article.